Celestone Soluspan

   
Google
 
Web NewDrugInformation.com

Celestone Soluspan


Drug - Celestone Soluspan
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Betamethasone Acetate; Betamethasone Sodium Phosphate
Multiple ingredients are in alphabetical order.

Strength - 3MG/ML;EQ 3MG BASE/ML
The potency of the active ingredient(s), Betamethasone Acetate; Betamethasone Sodium Phosphate. May repeat for multiple part products.

Applicant - SCHERING
The firm name holding legal responsibility for Celestone Soluspan. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 014602
The FDA assigned number to Celestone Soluspan. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Celestone Soluspan. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Celestone Soluspan was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Celestone Soluspan. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Celestone Soluspan is in. Format is RX, OTC, DISCN.

Applicant Full Name - Schering Corp Sub Schering Plough Corp
The full name of the firm holding legal responsibility for the new application of Celestone Soluspan.

Celestone Soluspan